NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
2.290
-0.040 (-1.70%)
At close: Feb 21, 2025, 4:00 PM
2.310
+0.020 (0.87%)
After-hours: Feb 21, 2025, 4:00 PM EST
NeurAxis Employees
NeurAxis had 19 employees as of December 31, 2023. The number of employees increased by 1 or 5.56% compared to the previous year.
Employees
19
Change (1Y)
1
Growth (1Y)
5.56%
Revenue / Employee
$129,275
Profits / Employee
-$443,722
Market Cap
16.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19 | 1 | 5.56% |
| Dec 31, 2022 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
NRXS News
- 4 weeks ago - UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States - GlobeNewsWire
- 4 weeks ago - NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States - GlobeNewsWire
- 5 weeks ago - NeurAxis Inc. Issues Letter to Shareholders - GlobeNewsWire
- 6 weeks ago - NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - GlobeNewsWire
- 3 months ago - NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues - GlobeNewsWire
- 4 months ago - NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewsWire
- 5 months ago - NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewsWire